drug
mifomelatide
Phase 2updated 3mo agoby Kalohexis LLC
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying mifomelatide
News(1)
- Pfizer axes ex-Metsera obesity asset and GIPR prospect in quarterly clearoutPfizer has axed two clinical-stage obesity programs, dropping a GLP-1 receptor agonist from the Metsera buyout and a GIPR antagonist as part of its quarterly pipeline cleanout.fiercebiotech · 14d ago
Data sources
last refreshed 2m ago
Found something off?
comments(0)
5-min edit window · permanent after that